Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization

被引:11
|
作者
Walstab, Jutta [1 ]
Steinhagen, Folkert [1 ]
Bruess, Michael [1 ]
Goethert, Manfred [1 ]
Boenisch, Heinz [1 ]
机构
[1] Univ Bonn, Inst Pharmacol & Toxicol, D-53105 Bonn, Germany
关键词
aequorin; calcium; 5-HT2C receptor; C23S variant; receptor desensitization; inverse agonist; SB; 206553; HEK293; cells; CONSTITUTIVELY ACTIVE MUTANT; AIRWAY SMOOTH-MUSCLE; BETA(2)-ADRENERGIC RECEPTOR; SIGNAL-TRANSDUCTION; SEROTONIN RECEPTOR; 5-HYDROXYTRYPTAMINE(2C) RECEPTORS; RAPID DESENSITIZATION; CLOZAPINE RESPONSE; POLYMORPHISM; GENE;
D O I
10.1016/S1734-1140(11)70397-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to analyze functional properties of the naturally occurring C23S variant of the human 5-HT2C receptor. In HEK293 cells transiently expressing the unedited forms of the variant receptor (VR) or the wild-type receptor (WTR), surface expression was determined by [H-3]mesulergine binding to membrane fragments. Function was examined by an aequorin luminescence-based Ca2+ assay. Surface expression of the VR was 116% of that of the WTR. The 5-HT-induced increase in cytosolic ([Ca2+](i)), and its inhibition by the inverse agonist SB 206553 did not differ between VR- or WTR-expressing cells. Preexposure of VR- or WTR-expressing cells to 0.5 mu M 5-HT (3 min-4.5 h) led to a practically identical time course and extent in the reduction of the 5-HT-induced increase in [Ca2+](i). In contrast, prolonged preexposure to the inverse agonist SB 206553 (1 mu M) elevated the 5-HT-induced increase in [Ca2+]; for both isoreceptors. A preexposure time of 4.5 h was necessary to significantly elevate the Ca2+ response of the WTR, but the VR produced this elevation within 1 h with virtually no further effect after 4.5 h of preexposure. In conclusion, prolonged preexposure to 5-HT caused equally rapid and strong desensitization of both isoreceptors. The different time course of SB 206553-induced resensitization of the two isoreceptors might be therapeutically relevant for drugs exhibiting inverse agonist properties at 5-HT2C receptors, such as atypical antipsychotics and certain antidepressants.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 50 条
  • [21] Agonist-induced phosphorylation of the serotonin 5-HT2C receptor regulates its interaction with multiple PDZ protein 1
    Parker, LL
    Backstrom, JR
    Sanders-Bush, E
    Shieh, BH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) : 21576 - 21583
  • [22] The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B
    Laura C. Scarlota
    John A. Harvey
    Vincent J. Aloyo
    Psychopharmacology, 2011, 213 : 393 - 401
  • [23] The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B
    Scarlota, Laura C.
    Harvey, John A.
    Aloyo, Vincent J.
    PSYCHOPHARMACOLOGY, 2011, 213 (2-3) : 393 - 401
  • [24] A unique phenotype of 5-HT2C agonist-induced GTPγ35S binding, transferable to 5-HT2A and 5-HT2B, upon swapping intracellular regions
    Alberts, GL
    Chio, CL
    Bin Im, W
    Slightom, JL
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (03) : 427 - 434
  • [25] Further pharmacological characterization of 5-HT2C receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo
    Queree, P.
    Peters, S.
    Sharp, T.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (06) : 1477 - 1485
  • [26] Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors
    Knight, AR
    Misra, A
    Quirk, K
    Benwell, K
    Revell, D
    Kennett, G
    Bickerdike, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 370 (02) : 114 - 123
  • [27] Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors
    Antony R. Knight
    Anil Misra
    Kathleen Quirk
    Karen Benwell
    Dean Revell
    Guy Kennett
    Mike Bickerdike
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 370 : 114 - 123
  • [28] Evaluation of Prolactin as a Useful Pharmacodynamic Tool to Assess Engagement of Central 5-HT2C Receptors by LP352, a Potent and Selective 5-HT2C Agonist
    Chan, R.
    Mclin, D.
    Kaye, R.
    EPILEPSIA, 2023, 64 : 305 - 306
  • [29] Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy
    Schaerlinger, B
    Hickel, P
    Etienne, N
    Guesnier, L
    Maroteaux, L
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (02) : 277 - 284
  • [30] Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT2A and 5-HT2C receptors
    Acuña-Castillo, C
    Villalobos, C
    Moya, PR
    Sáez, P
    Cassels, BK
    Huidobro-Toro, J
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (04) : 510 - 519